Times are displayed in (UTC-05:00) Central Time (US & Canada) Change
5/6/2024 | 2:15 PM – 3:30 PM | Exhibit Hall F1
Poster Session—Immunotherapy and Cancer Vaccines (PM)
Vaccination with spermine binding protein (p25) peptide provides effective immunotherapy against prostate tumors
(P204)Presentation Time: 02:15 PM–03:30 PM
Posterboard Number: 204
Abstract ID: 4373
Presenting Author:
Isabella Haslinger Johnson, Western Reserve Acad.
Co-Authors:
Ethan Jing, Western Reserve Acad.; Sehar Mahesh, Western Reserve Acad.; Roberto Aguilar, Western Reserve Acad.;
View Abstract Details
Generation of a novel agonist of the human CD137 costimulatory pathway for cancer immunotherapy
(P208)Presentation Time: 02:15 PM–03:30 PM
Posterboard Number: 208
Abstract ID: 4949
Presenting Author:
Christa D. Jackson, Univ. of Missouri Sch. of Med.
Co-Authors:
Feyza Nur Arguc, Univ. of Missouri Sch. of Med.; Vahap Ulker, Univ. of Missouri Sch. of Med.; Noah Powell, Univ. of Missouri Sch. of Med.; Esma S. Yolcu, Univ. of Missouri Sch. of Med.; Haval Shirwan, Univ. of Missouri Sch. of Med.;
View Abstract Details
Peptide-pulsed MHC class II allogeneic dendritic cell vaccine has superior efficacy providing allogeneic help in a murine cancer model.
(P210)Presentation Time: 02:15 PM–03:30 PM
Posterboard Number: 210
Abstract ID: 4946
Presenting Author:
Noriko Seishima, NCI, NIH
Co-Authors:
William Becker, NCI, NIH; Purevdorj B Olkhanud, NCI, NIH; Hoyoung Maeng, NCI, NIH; Miguel Lopez-Lago, BriaCell; Charles Wiseman, BriaCell; William V Williams, BriaCell; Jay A Berzofsky, NCI, NIH;
View Abstract Details
PD1 blockade improves survival and CD8+ cytotoxic capacity, without increasing inflammation, during normal microbial experience in old mice
(P214)Presentation Time: 02:15 PM–03:30 PM
Posterboard Number: 214
Abstract ID: 5536
Presenting Author:
Korbyn JV Dahlquist, Univ. of Minnesota, Twin Cities
Co-Authors:
Matthew A Huggins, Univ. of Minnesota, Twin Cities; Matthew J Yousefzadeh, Univ. of Minnesota, Twin Cities; Carolina Soto-Palma, Univ. of Minnesota, Twin Cities; Stephanie H Cholensky, Univ. of Minnesota, Twin Cities; Mark Pierson, Univ. of Minnesota, Twin Cities; Declan M Smith, Univ. of Minnesota, Twin Cities; Sara E Hamilton, Univ. of Minnesota, Twin Cities; Christina D Camell, Univ. of Minnesota, Twin Cities;
View Abstract Details
Towards optimizing cancer immunotherapeutic index: anti-CD3e Mono-Fab, a novel T cell-based therapeutic approach with less auto-Immunogenic profile.
(P216)Presentation Time: 02:15 PM–03:30 PM
Posterboard Number: 216
Abstract ID: 5317
Presenting Author:
Onyekachi J Okpasuo, Univ. of Missouri, Columbia
Co-Authors:
Chandrashekara Puthanapura Mahadevappa, Univ. of Missouri, Columbia; Hien Huynh, Univ. of Missouri, Columbia; Christa Cheatam, Univ. of Missouri, Columbia; Vijay Radhakrishnan, Univ. of Missouri, Columbia; Habib Zaghouani, Univ. of Missouri, Columbia; Craig L. Franklin, Univ. of Missouri, Columbia; Adam G Schrum, Univ. of Missouri, Columbia; Diana Gil, Univ. of Missouri, Columbia;
View Abstract Details
An engineered viral protein rewires signaling pathways to overcome T cell suppression.
(P218)Presentation Time: 02:15 PM–03:30 PM
Posterboard Number: 218
Abstract ID: 5719
Presenting Author:
Yating Zheng, Univ. of Michigan Med. Sch.
Co-Authors:
Zehui Gu, Univ. of Michigan Med. Sch.; Claire E. Shudde, Univ. of Michigan Med. Sch.; Taylor L. Piper, Univ. of Michigan Med. Sch.; Xinyu Wang, Univ. of Michigan Med. Sch.; Grace Aleck, Univ. of Michigan Med. Sch.; Jiajia Zhou, Univ. of Michigan Rogel Cancer Ctr.; Monica K. Chanda, Univ. of Michigan Med. Sch.; Lilliana Trinch, Univ. of Michigan Med. Sch.; Weiping Zou, Univ. of Michigan Rogel Cancer Ctr.; Adam H. Courtney, Univ. of Michigan Med. Sch.;
View Abstract Details
Durable epigenetic reprogramming of exhausted CD8 T cells by microRNA-29a
(P220)Presentation Time: 02:15 PM–03:30 PM
Posterboard Number: 220
Abstract ID: 5922
Presenting Author:
Lance A Buchness, Univ. of Miami Miller Sch. of Med., Sylvester Comp. Cancer Ctr., Univ. of Miami Hlth. Sys.
Co-Authors:
Xuebing Leng, Sylvester Comp. Cancer Ctr., Univ. of Miami Hlth. Sys.; Christine Rafie, Sylvester Comp. Cancer Ctr., Univ. of Miami Hlth. Sys.; Svetlana Ristin, Sylvester Comp. Cancer Ctr., Univ. of Miami Hlth. Sys.; Yuan-De Tan, Univ. of Miami Miller Sch. of Med.; Corneliu Sologon, Sylvester Comp. Cancer Ctr., Univ. of Miami Hlth. Sys.; Aaron Ruby, Sylvester Comp. Cancer Ctr., Univ. of Miami Hlth. Sys.; Benjamin Currall, Univ. of Miami Miller Sch. of Med.; Alejandro Moro, Sylvester Comp. Cancer Ctr., Univ. of Miami Hlth. Sys.; Sion Williams, Univ. of Miami Miller Sch. of Med.; Yuguang Ban, Univ. of Miami Miller Sch. of Med.; Erietta Stelekati, Sylvester Comp. Cancer Ctr., Univ. of Miami Hlth. Sys.;
View Abstract Details
A Self-Assembling Vaccine, VTX-067, targeting E6/E7 proteins of Human Papilloma Virus Induces T Cell-Mediated Immune Responses and Inhibits HPV E6/E7 Expressing Tumor Growth in a C57/B6 Mouse Model.
(P222)Presentation Time: 02:15 PM–03:30 PM
Posterboard Number: 222
Abstract ID: 6108
Presenting Author:
Yohannes Gemechu, Massachusetts Gen. Hosp., Harvard Med. Sch.
Co-Authors:
Sonia Mukherjee, Massachusetts Gen. Hosp., Harvard Med. Sch.; Jeffrey A Gelfand, Massachusetts Gen. Hosp., Harvard Med. Sch.; Timothy A Brauns, Massachusetts Gen. Hosp., Harvard Med. Sch.; Ann E Sluder, Massachusetts Gen. Hosp., Harvard Med. Sch.; Pierre R Leblanc, Massachusetts Gen. Hosp., Harvard Med. Sch.; George Steinfels, Voltron Therapeut.; Paul Korner, Voltron Therapeut.; Ishan Capila, Voltron Therapeut.; Zachary Shriver, Voltron Therapeut.; Patrick M Reeves, Massachusetts Gen. Hosp., Harvard Med. Sch.; Mark C Poznansky, Massachusetts Gen. Hosp., Harvard Med. Sch.;
View Abstract Details
PD-1 and CD73 synergistically limit CD4 T cell responses to autoantigens
(P224)Presentation Time: 02:15 PM–03:30 PM
Posterboard Number: 224
Abstract ID: 6106
Presenting Author:
Felix S Nettersheim, La Jolla Inst. for Immunol.
Co-Authors:
Simon Brunel, La Jolla Inst. for Immunol.; Robert S Sinkovits, UCSD; Sujit S Armstrong, La Jolla Inst. for Immunol.; Payel Roy, La Jolla Inst. for Immunol.; Monica Billitti, La Jolla Inst. for Immunol.; Kouji Kobiyama, La Jolla Inst. for Immunol.; Lihui Lu, La Jolla Inst. for Immunol.; Chris A Benedict, La Jolla Inst. for Immunol.; Florin Vaida, UCSD; Allesandro Sette, La Jolla Inst. for Immunol.; Bjoern Peters, La Jolla Inst. for Immunol.; Thamotharampillai Dileepan, Univ. of Minnesota Med. Sch.; Marc K Jenkins, Univ. of Minnesota Med. Sch.; Klaus Ley, La Jolla Inst. for Immunol.;
View Abstract Details
.
(P226)Presentation Time: 02:15 PM–03:30 PM
Posterboard Number: 226
Abstract ID: 4652
Presenting Author:
Afrooz Dabbaghizadeh, Ctr. Hosp. de Univ. de Montréal, Univ. de Montréal
Co-Authors:
Jessica Dion, Ctr. Hosp. de Univ. de Montréal; Yousef Maali, Ctr. Hosp. de Univ. de Montréal; Ahmed Fouda, McGill Univ.; Nathalie Bédard, Ctr. Hosp. de Univ. de Montréal; Jean Tchervenkov, McGill Univ.; Naglaa H. Shoukry, Ctr. Hosp. de Univ. de Montréal;
View Abstract Details